Cardiacare

CardiaCare is a medical device company developing the world’s first non-invasive neuromodulation therapy for AFib, delivered through a discreet, easy-to-use wearable. The device combines proprietary neuromodulation technology with AI-enabled cardiac rhythm monitoring to deliver personalized, closed-loop therapy at home. Unlike current treatments that rely on invasive ablation procedures or chronic medications with limited efficacy and extensive side effects, CardiaCare provides patients with a safe, comfortable, and accessible alternative management tool.